Novel Endoscopic Treatment Improves Glycemic Control and Eliminates Need for Insulin in Patients with Type 2 Diabetes
In a first-in-human study, 86% of patients were able to stop insulin after a single electroporation therapy combined with a GLP-1 receptor agonist.